Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
The first-time AOM semaglutide prescribing rate was 0.1% in January 2024 and reached 0.2% by July 2024
As of February 2025, the FDA declared that the semaglutide shortage was resolved
With decades of research and applied experience, Michael specializes in translating complex biological mechanisms into clear, accurate, and accessible educational content
Brain, Behavior, and Immunity
A recent phase three program showed it improved A1C (a three-month average of blood sugar) more than comparators [the drugs it was tested against] and led to significant weight loss, with side effects mostly in the digestive tract (nausea, vomiting [and] diarrhea), like other GLP-1 drugs. Wegovy pill Orforglipron isnt the only pill-form GLP-1 generating excitement
The next step is a Phase 1 clinical trial, which is a significant and resource-intensive milestone that requires an external partner
US$ 23.84
US$ 28.48
US$ 22.04
